Clinical Trial Update: Mesalazine Effects in Sporadic Colorectal Adenoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mesalazine in patients with sporadic colorectal adenoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: UMC Utrecht | Conditions: Sporadic Colorectal Adenoma | Phase 2 | Status: COMPLETED